Advanced Imaging for Precise Liver Cancer Detection

Glypican-3 (GPC3) Digital PET/CT Scan

A targeted PET/CT scan that binds to Glypican-3 receptors, enabling accuratedetection and characterization of hepatocellular carcinoma (HCC) lesions.

About GPC3 PET/CT Scan

A Glypican-3 (GPC3) PET/CT scan is an advanced molecular imaging technique used for the diagnosis, staging, and treatment planning of hepatocellular carcinoma (HCC), the most common primary liver cancer.

This imaging modality combines two powerful technologies:

Positron Emission Tomography (PET)

detects molecular activity

Positron Emission Tomography (PET)

detects molecular activity

Why is a GPC3 PET/CT Scan Performed?

GPC3 PET/CT plays a crucial role in the evaluation of hepatocellular carcinoma. Key
clinical applications include:

01. Detection of Hepatocellular Carcinoma

GPC3 PET/CT enables highly specific detection of HCC lesions.

02. Accurate Tumor Staging

The scan helps determine the extent of disease within the liver and identifies spread to lymph nodes or distant organs, aiding precise staging.

03. Detection of Extrahepatic Metastases

GPC3 PET/CT can identify small metastatic deposits in lungs, bones, or lymph nodes that may be missed on routine imaging.

04. Assessment of Treatment Response

This scan is valuable in monitoring response to:
  • Targeted therapies
  • Immunotherapy
  • Locoregional therapies (TACE, RFA)
  • It helps differentiate viable tumor tissue from necrosis or post-treatment changes.

    05. Selection for Targeted & Theranostic Approaches

    GPC3 imaging helps identify patients who may benefit from GPC3-targeted therapies, radioligand treatments.

    Subsribe To Our Newsletter

    Stay in touch with us to get latest news and special offers.

    Address

    Aster Whitefield Hospital Plot No. 3 & 4, Sadaramangala Industrial Area, off Whitefield Main Road, opposite ITPL, Whitefield, Bengaluru, Karnataka 560066

    Call Us

    +91 70223 10444

    Email Us

    prathapnuclearoncology@gmail.com